Back to Search
Start Over
Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review
- Source :
- Journal of Drugs in Dermatology. 20:192-198
- Publication Year :
- 2021
- Publisher :
- SanovaWorks, 2021.
-
Abstract
- Background Surgical excision is the paradigm treatment option for non-melanoma skin cancer (NMSC), however intralesional fluorouracil (IL 5-FU) is an efficacious alternative and superior to other chemotherapy agents in NMSC. Yet, little summative data exists on the topic. Objective To assess the efficacy of IL 5-FU in the treatment of NMSC. Methods and materials A systematic review was performed using PubMed, Embase and Web of Science databases. 19 studies were included. ANOVA test was used to compare the duration of lesion prior to therapy and resolution time following IL 5-FU treatment. A two-way proportion test was performed to compare the clearance rate between squamous cell carcinoma (SCC), basal cell carcinoma (BCC), and keratoacanthoma (KA). Results There was no significant difference between the clearance rate of SCC and BCC after IL 5-FU therapy (87 % vs 91.4%, respectively; P=0.2); however, the clearance rate of both SCC and BCC was significantly greater than that of KA (74.5%; Pl0.007); 95% CI [2.56%n19.1%]. Lesion duration and resolution time did not significantly differ across SCC, BCC, and KA (Pg0.3). Conclusion While majority of data is derived from individual cases, IL 5-FU achieved higher clearance rate in SCC and BCC groups than in KA group. J Drugs Dermatol. 2021;20(2):192-198. doi:10.36849/JDD.2021.5518.
- Subjects :
- medicine.medical_specialty
Keratoacanthoma
Skin Neoplasms
Biopsy
medicine.medical_treatment
Injections, Intralesional
030226 pharmacology & pharmacy
Gastroenterology
Drug Administration Schedule
Lesion
03 medical and health sciences
0302 clinical medicine
Internal medicine
medicine
Humans
Basal cell carcinoma
Skin
Chemotherapy
business.industry
General Medicine
medicine.disease
Treatment Outcome
Carcinoma, Basal Cell
Fluorouracil
030220 oncology & carcinogenesis
Carcinoma, Squamous Cell
Skin cancer
medicine.symptom
business
Clearance rate
Non melanoma
medicine.drug
Subjects
Details
- ISSN :
- 15459616
- Volume :
- 20
- Database :
- OpenAIRE
- Journal :
- Journal of Drugs in Dermatology
- Accession number :
- edsair.doi.dedup.....0bd01709c71410dd62e2fd6ac5d046c7